BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 11160151)

  • 1. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.
    Calvi LM; Sims NA; Hunzelman JL; Knight MC; Giovannetti A; Saxton JM; Kronenberg HM; Baron R; Schipani E
    J Clin Invest; 2001 Feb; 107(3):277-86. PubMed ID: 11160151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments.
    Chiusaroli R; Maier A; Knight MC; Byrne M; Calvi LM; Baron R; Krane SM; Schipani E
    Endocrinology; 2003 Sep; 144(9):4106-16. PubMed ID: 12933685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
    Marsell R; Jonsson KB; Cho TJ; Einhorn TA; Ohlsson C; Schipani E
    Acta Orthop; 2007 Feb; 78(1):39-45. PubMed ID: 17453391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
    Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
    Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblastic cells regulate the haematopoietic stem cell niche.
    Calvi LM; Adams GB; Weibrecht KW; Weber JM; Olson DP; Knight MC; Martin RP; Schipani E; Divieti P; Bringhurst FR; Milner LA; Kronenberg HM; Scadden DT
    Nature; 2003 Oct; 425(6960):841-6. PubMed ID: 14574413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development.
    Kondo H; Ohyama T; Ohya K; Kasugai S
    J Bone Miner Res; 1997 Dec; 12(12):2089-97. PubMed ID: 9421242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.
    Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD
    Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development.
    Amizuka N; Karaplis AC; Henderson JE; Warshawsky H; Lipman ML; Matsuki Y; Ejiri S; Tanaka M; Izumi N; Ozawa H; Goltzman D
    Dev Biol; 1996 Apr; 175(1):166-76. PubMed ID: 8608863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone.
    Lanske B; Divieti P; Kovacs CS; Pirro A; Landis WJ; Krane SM; Bringhurst FR; Kronenberg HM
    Endocrinology; 1998 Dec; 139(12):5194-204. PubMed ID: 9832460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption.
    Ono N; Nakashima K; Schipani E; Hayata T; Ezura Y; Soma K; Kronenberg HM; Noda M
    J Biol Chem; 2007 Aug; 282(35):25509-16. PubMed ID: 17500070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats.
    Fermor B; Skerry TM
    J Bone Miner Res; 1995 Dec; 10(12):1935-43. PubMed ID: 8619374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
    Bedi B; Li JY; Tawfeek H; Baek KH; Adams J; Vangara SS; Chang MK; Kneissel M; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E725-33. PubMed ID: 22393015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.